Cancer Dynamics
- Autores
- Gandía, Daniel; Suárez, Cecilia Ana
- Año de publicación
- 2020
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Even though cancer researchers nowadays are trying to develop many key cellular pathways susceptible to be tackled by therapeutic approaches, we are far from being able to consider some cancers as curable diseases in general terms. From a pharmacodynamic point of view, the main potential molecular targets involved are driver oncogenes, tumor suppressor genes, growth factors and their receptors, transcription factors, tyrosine kinases, and cell adhesion molecules. If we consider possible targets at higher organization levels, we can intervene in aspects such as chromatin organzation, tumor microenvironment, angiogenesis, apoptosis, senescence, mitochondria metabolism, and immune pathways.
Fil: Gandía, Daniel. Sanatorio Los Arcos; Argentina
Fil: Suárez, Cecilia Ana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Física del Plasma. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Física del Plasma; Argentina - Materia
-
CANCER
CANCER TREATMENTS
PERSONALIZED MEDICINE - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/146707
Ver los metadatos del registro completo
id |
CONICETDig_6287542f5b00d9cfbf4f77816fdf1435 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/146707 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Cancer DynamicsGandía, DanielSuárez, Cecilia AnaCANCERCANCER TREATMENTSPERSONALIZED MEDICINEhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Even though cancer researchers nowadays are trying to develop many key cellular pathways susceptible to be tackled by therapeutic approaches, we are far from being able to consider some cancers as curable diseases in general terms. From a pharmacodynamic point of view, the main potential molecular targets involved are driver oncogenes, tumor suppressor genes, growth factors and their receptors, transcription factors, tyrosine kinases, and cell adhesion molecules. If we consider possible targets at higher organization levels, we can intervene in aspects such as chromatin organzation, tumor microenvironment, angiogenesis, apoptosis, senescence, mitochondria metabolism, and immune pathways.Fil: Gandía, Daniel. Sanatorio Los Arcos; ArgentinaFil: Suárez, Cecilia Ana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Física del Plasma. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Física del Plasma; ArgentinaOpenventio Publishers2020-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/146707Gandía, Daniel; Suárez, Cecilia Ana; Cancer Dynamics; Openventio Publishers; Cancer Studies and Molecular Medicine; 6; 1; 6-2020; 1-42377-1518CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://openventio.org/category/journal-index/cancer-studies-and-molecular-medicine-open-journal-csmmoj/#info:eu-repo/semantics/altIdentifier/doi/10.17140/CSMMOJ-6-130info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-22T11:19:10Zoai:ri.conicet.gov.ar:11336/146707instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-22 11:19:11.209CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Cancer Dynamics |
title |
Cancer Dynamics |
spellingShingle |
Cancer Dynamics Gandía, Daniel CANCER CANCER TREATMENTS PERSONALIZED MEDICINE |
title_short |
Cancer Dynamics |
title_full |
Cancer Dynamics |
title_fullStr |
Cancer Dynamics |
title_full_unstemmed |
Cancer Dynamics |
title_sort |
Cancer Dynamics |
dc.creator.none.fl_str_mv |
Gandía, Daniel Suárez, Cecilia Ana |
author |
Gandía, Daniel |
author_facet |
Gandía, Daniel Suárez, Cecilia Ana |
author_role |
author |
author2 |
Suárez, Cecilia Ana |
author2_role |
author |
dc.subject.none.fl_str_mv |
CANCER CANCER TREATMENTS PERSONALIZED MEDICINE |
topic |
CANCER CANCER TREATMENTS PERSONALIZED MEDICINE |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Even though cancer researchers nowadays are trying to develop many key cellular pathways susceptible to be tackled by therapeutic approaches, we are far from being able to consider some cancers as curable diseases in general terms. From a pharmacodynamic point of view, the main potential molecular targets involved are driver oncogenes, tumor suppressor genes, growth factors and their receptors, transcription factors, tyrosine kinases, and cell adhesion molecules. If we consider possible targets at higher organization levels, we can intervene in aspects such as chromatin organzation, tumor microenvironment, angiogenesis, apoptosis, senescence, mitochondria metabolism, and immune pathways. Fil: Gandía, Daniel. Sanatorio Los Arcos; Argentina Fil: Suárez, Cecilia Ana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Física del Plasma. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Física del Plasma; Argentina |
description |
Even though cancer researchers nowadays are trying to develop many key cellular pathways susceptible to be tackled by therapeutic approaches, we are far from being able to consider some cancers as curable diseases in general terms. From a pharmacodynamic point of view, the main potential molecular targets involved are driver oncogenes, tumor suppressor genes, growth factors and their receptors, transcription factors, tyrosine kinases, and cell adhesion molecules. If we consider possible targets at higher organization levels, we can intervene in aspects such as chromatin organzation, tumor microenvironment, angiogenesis, apoptosis, senescence, mitochondria metabolism, and immune pathways. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-06 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/146707 Gandía, Daniel; Suárez, Cecilia Ana; Cancer Dynamics; Openventio Publishers; Cancer Studies and Molecular Medicine; 6; 1; 6-2020; 1-4 2377-1518 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/146707 |
identifier_str_mv |
Gandía, Daniel; Suárez, Cecilia Ana; Cancer Dynamics; Openventio Publishers; Cancer Studies and Molecular Medicine; 6; 1; 6-2020; 1-4 2377-1518 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://openventio.org/category/journal-index/cancer-studies-and-molecular-medicine-open-journal-csmmoj/# info:eu-repo/semantics/altIdentifier/doi/10.17140/CSMMOJ-6-130 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Openventio Publishers |
publisher.none.fl_str_mv |
Openventio Publishers |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1846781665792229376 |
score |
13.229304 |